Badzioch M, Eeles R, Leblanc G, Foulkes WD, Giles G, Edwards S, Goldgar D, Hopper JL, Bishop DT, Moller P, Heimdal K, Easton D, Simard J. Suggestive evidence for a site specific prostate cancer gene on chromosome 1p36. The CRC/BPG UK Familial Prostate Cancer Study Coordinators and Collaborators. The EU Biomed Collaborators [letter] J Med Genet, vol. 37, 2000:947-9.
Frydenberg M, Giles GG, Mameghan H, Thursfield VJ, Millar J, Wheelahan JB, Bolton DM, Syme RR. Prostate cancer in Victoria in 1993: patterns of reported management. Med J Aust 2000;172:270-4.
Hammond SR, English DR, McLeod JG. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000;123:968-74.
Hammond SR, McLeod JG, Macaskill P, English DR. Multiple sclerosis in Australia: prognostic factors. J Clin Neurosci 2000;7:16-9.
Harrap SB, Stebbing M, Hopper JL, Hoang HN, Giles GG. Familial patterns of covariation for cardiovascular risk factors in adults: The Victorian Family Heart Study. Am J Epidemiol 2000;152:704-15.
Hodge A, Patterson AJ, Brown WJ, Ireland P, Giles G. The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 2000;24:576-83.
Hopper JL, Firgaira FA, Dite GS, Giles GG, McCredie MR, Southey MC, Venter DJ, Seshadri R, McEvoy CR. RESPONSE: re: HRAS1 rare minisatellite alleles and breast cancer in australian women under age forty years [letter] J Natl Cancer Inst, vol. 92, 2000:756-7.
Huttley GA, Easteal S, Southey MC, Tesoriero A, Giles GG, McCredie MR, Hopper JL, Venter DJ. Adaptive evolution of the tumour suppressor BRCA1 in humans and chimpanzees. Australian Breast Cancer Family Study. Nat Genet 2000;25:410-3.
Kavanagh AM, Giles GG, Mitchell H, Cawson JN. The sensitivity, specificity, and positive predictive value of screening mammography and symptomatic status. J Med Screen 2000;7:105-10.
Kavanagh AM, Mitchell H, Giles GG. Hormone replacement therapy and accuracy of mammographic screening. Lancet 2000;355:270-4.
Milne E, English DR, Johnston R, Cross D, Borland R, Costa C, Giles-Corti B. Improved sun protection behaviour in children after two years of the Kidskin intervention. Aust N Z J Public Health 2000;24:481-7.
Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF. kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust 2000;172:463-4.
Richardson GE, Thursfield VJ, Giles GG. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. Med J Aust 2000;172:321-4.
Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer 2000;82:1887-91.
Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG. Impaired fasting glucose: how low should it go? Diabetes Care 2000;23:34-9.
Singh R. No evidence of linkage to chromosome 1q42.2-43 in 131 prostate cancer families from the ACTANE consortium. Anglo, Canada, Texas, Australia, Norway, EU Biomed. Br J Cancer 2000;83:1654-8.
Spurdle AB, Hopper JL, Dite GS, Chen X, Cui J, McCredie MR, Giles GG, Southey MC, Venter DJ, Easton DF, Chenevix-Trench G. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2000;92:1674-81.
Spurdle AB, Webb PM, Chen X, Martin NG, Giles GG, Hopper JL, Chenevix-Trench G. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer. Int J Cancer 2000;87:637-43.
Xu J. Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet 2000;66:945-57.
Autier P, Boniol M, Severi G, Giles G, Cattaruzza MS, Luther H, Renard F, Grivegnee AR, Pedeux R, Dore JF. The body site distribution of melanocytic naevi in 6-7 year old European children. Melanoma Res 2001;11:123-31.
Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001;134:1087-95.
Cui J, Antoniou AC, Dite GS, Southey MC, Venter DJ, Easton DF, Giles GG, McCredie MR, Hopper JL. After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet 2001;68:420-31.
Cui J, Staples MP, Hopper JL, English DR, McCredie MR, Giles GG. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet 2001;68:1207-18.
Giles G, Russell I, Reed R, Marr G, Kavanagh A. In situ and small invasive breast cancer register in Victoria, 1988 to 1992: tumour characteristics and patient management. ANZ J Surg 2001;71:266-70.
Giles GG, Severi G, McCredie MR, English DR, Johnson W, Hopper JL, Boyle P. Smoking and prostate cancer: findings from an Australian case-control study. Ann Oncol 2001;12:761-5.
Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Leptin and other components of the Metabolic Syndrome in Mauritius--a factor analysis. Int J Obes Relat Metab Disord 2001;25:126-31.
Holman CD, Arnold-Reed DE, de Klerk N, McComb C, English DR. A psychometric experiment in causal inference to estimate evidential weights used by epidemiologists. Epidemiology 2001;12:246-55.
McCredie M, Staples M, Johnson W, English DR, Giles GG. Prevalence of urinary symptoms in urban Australian men aged 40-69. J Epidemiol Biostat 2001;6:211-8.
McCredie MR, Dite GS, Porter L, Maskiell J, Giles GG, Phillips KA, Redman S, Hopper JL. Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast 2001;10:515-22.
Milne E, English DR, Johnston R, Cross D, Borland R, Giles-Corti B, Costa C. Reduced sun exposure and tanning in children after 2 years of a school-based intervention (Australia). Cancer Causes Control 2001;12:387-93.
Morgan TO, Anderson AI, MacInnis RJ. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension. Am J Hypertens 2001;14:241-7.
Nowson CA, MacInnis RJ, Hopper JL, Alexander JL, Paton LM, Margerison C, Wark JD. Association of birth weight and current body size to blood pressure in female twins. Twin Res 2001;4:378-84.
Spurdle AB, Hopper JL, Chen X, Dite GS, McCredie MR, Giles GG, Venter DJ, Southey MC, Purdie DM, Chenevix-Trench G. The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. Cancer Epidemiol Biomarkers Prev 2001;10:1287-93.
Stoney RM, O'Dea K, Herbert KE, Dragicevic G, Giles GG, Cumpston GN, Best JD. Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with Type 2 diabetes mellitus. Diabet Med 2001;18:476-82.
Toner GC, Neerhut GJ, Schwarz MA, Thursfield VJ, Sandeman TF, Giles GG, Snow RM. The management of testicular cancer in Victoria, 1988-1993. Urology Study Committee of the Victorian Co-operative Oncology Group. Med J Aust 2001;174:328-31.
Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Eye color and cutaneous nevi predict risk of ocular melanoma in Australia. Int J Cancer 2001;92:906-12.
Young D, Hopper JL, Macinnis RJ, Nowson CA, Hoang NH, Wark JD. Changes in body composition as determinants of longitudinal changes in bone mineral measures in 8 to 26-year-old female twins. Osteoporos Int 2001;12:506-15.
Boyd NF, Dite GS, Stone J, Gunasekara A, English DR, McCredie MR, Giles GG, Tritchler D, Chiarelli A, Yaffe MJ, Hopper JL. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002;347:886-94.
Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002;138:609-14.
English DR, Vu HT, Knuiman MW. The impact of smoking on use of hospital services: the Busselton study. Aust N Z J Public Health 2002;26:225-30.
Farmer KC, Penfold C, Millar JL, Zalcberg J, McLeish JA, Thomas RJ, Lade S, Thursfield VJ, Giles GG. Rectal cancer in Victoria in 1994: patterns of reported management. ANZ J Surg 2002;72:265-70.
Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
Giles GG, Severi G, Sinclair R, English DR, McCredie MR, Johnson W, Boyle P, Hopper JL. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study. Cancer Epidemiol Biomarkers Prev 2002;11:549-53.
Grossi M, Quinn MA, Thursfield VJ, Francis PA, Rome RM, Planner RS, Giles GG. Ovarian cancer: patterns of care in Victoria during 1993-1995. Med J Aust 2002;177:11-6.
Haydon AM, Jass JR. Emerging pathways in colorectal-cancer development. Lancet Oncol 2002;3:83-8.
Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, Mead LJ, St John DJ, Macrae FA, Bishop DT, Venter DJ, Giles GG, Hopper JL. After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer 2002;102:166-71.
McLeish JA, Thursfield VJ, Giles GG. Survival from colorectal cancer in Victoria: 10-year follow up of the 1987 management survey. ANZ J Surg 2002;72:352-6.
Menegoz F, Little J, Colonna M, Arslan A, Preston-Martin S, Schlehofer B, Blettner M, Howe GR, Ryan P, Giles GG, Rodvall Y, Choi WN. Contacts with animals and humans as risk factors for adult brain tumours. An international case-control study. Eur J Cancer 2002;38:696-704.
Milne E, Johnston R, Cross D, Giles-Corti B, English DR. Effect of a school-based sun-protection intervention on the development of melanocytic nevi in children. Am J Epidemiol 2002;155:739-45.
Spurdle AB, Goodwin B, Hodgson E, Hopper JL, Chen X, Purdie DM, McCredie MR, Giles GG, Chenevix-Trench G, Liddle C. The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. Pharmacogenetics 2002;12:355-66.
Spurdle AB, Hopper JL, Chen X, Dite GS, Cui J, McCredie MR, Giles GG, Ellis-Steinborner S, Venter DJ, Newman B, Southey MC, Chenevix-Trench G. The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. Cancer Epidemiol Biomarkers Prev 2002;11:413-6.
Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G. Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women. Lancet 2002;360:925-6.
Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Newman B, Chenevix-Trench G, Khanna K. No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer. Breast Cancer Res 2002;4:R15.
Spurdle AB, Hopper JL, Chen X, McCredie MR, Giles GG, Venter DJ, Southey MC, Chenevix-Trench G. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiol Biomarkers Prev 2002;11:439-43.
Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, SenieR, Daly MB, West D, Ostrander EA, Offit K, Peretz T, Osorio A, Benitez J, Nathanson KL, Sinilnikova OM, Olah E, Bignon YJ, Ruiz P, Badzioch MD, Vasen HF, Futreal AP, Phelan CM, Narod SA, Lynch HT, Ponder BA, Eeles RA, Meijers-Heijboer H, Stoppa-Lyonnet D, Couch FJ, Eccles DM, Evans DG, Chang-Claude J, Lenoir G, Weber BL, Devilee P, Easton DF, Goldgar DE, Stratton MR.Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proc Natl Acad Sci U S A 2002;99:827-31.
Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer 2002;101:175-82.
Asia Pacific Cohort Studies Collaboration, Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension 2003;42:69-75.
Asia Pacific Cohort Studies Collaboration, Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, MacMahon S. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens 2003;21:707-16.
Asia Pacific Cohort Studies Collaboration, Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, MacMahon S. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care 2003;26:360-6.
Asia Pacific Cohort Studies Collaboration, Zhang X, Patel A, Horibe H, Wu Z, Barzi F, Rodgers A, MacMahon S, Woodward M. Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol 2003;32:563-72.
Ball K, Crawford D, Ireland P, Hodge A. Patterns and demographic predictors of 5-year weight change in a multi-ethnic cohort of men and women in Australia. Public Health Nutr 2003;6:269-81.
Boyle P, Severi G, Giles GG. The epidemiology of prostate cancer. Urol Clin North Am 2003 May; 30:209-17.
Cui JS, Spurdle AB, Southey MC, Dite GS, Venter DJ, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL. Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer. Genet Epidemiol 2003;24:161-72.
Dite GS, Jenkins MA, Southey MC, Hocking JS, Giles GG, McCredie MR, Venter DJ, Hopper JL. Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations. J Natl Cancer Inst 2003;95:448-57.
Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ. Where are the prostate cancer genes?--A summary of eight genome wide searches. Prostate 2003;57:261-9.
Edwards S, Meitz J, Eles R, Evans C, Easton D, Hopper J, Giles G, Foulkes WD, Narod S, Simard J, Badzioch M, Mahle L. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium. Prostate 2003;57:270-9.
English DR, Burton RC, del Mar CB, Donovan RJ, Ireland PD, Emery G. Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice. BMJ 2003;327:375.
Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, Thomasx J, Hopper JL, Wark JD. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003;51:1533-8.
Giles GG. Epidemiological investigation of prostate cancer. Methods Mol Med 2003;81:1-19.
Giles GG, Amos A. Evaluation of the organised mammographic screening programme in Australia. Ann Oncol 2003;14:1209-11.
Giles GG, Severi G, English DR, McCredie MR, Borland R, Boyle P, Hopper JL. Sexual factors and prostate cancer. BJU Int 2003;92:211-6.
Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P, Hopper JL. Early growth, adult body size and prostate cancer risk. Int J Cancer 2003;103:241-5.
Haydon A. Adjuvant chemotherapy in colon cancer: what is the evidence? Intern Med J 2003;33:119-24.
Johnston R, Cross D, Costa C, Giles-Corti B, Cordin T, Milne E, English DR. Sun safety education intervention for school and home. Health Educ 2003;103:342-51.
MacInnis RJ, Cassar C, Nowson CA, Paton LM, Flicker L, Hopper JL, Larkins RG, Wark JD. Determinants of bone density in 30- to 65-year-old women: a co-twin study. J Bone Miner Res 2003;18:1650-6.
MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2003;12:1417-21.
McCredie MR, Dite GS, Southey MC, Venter DJ, Giles GG, Hopper JL. Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status. Br J Cancer 2003;89:1661-3.
Montgomery KG, Gertig DM, Baxter SW, Milne RL, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years. Cancer Epidemiol Biomarkers Prev 2003;12:1109-11.
Moot AR, Polglase A, Giles GG, Garson OM, Thursfield V, Gunter D. Men with colorectal cancer are predisposed to prostate cancer. ANZ J Surg 2003;73:289-93.
Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 2003;39:622-30.
Scott CI, Iorgulescu DG, Thorne HJ, Henderson MA, Phillips KA. Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy. Clin Genet 2003;64:111-21.
Severi G, Giles GG, Southey MC, Tesoriero A, Tilley W, Neufing P, Morris H, English DR, McCredie MR, Boyle P, Hopper JL. ELAC2/HPC2 Polymorphisms, Prostate-Specific Antigen Levels, and Prostate Cancer. J Natl Cancer Inst 2003;95:818-24.
Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol 2003;149:1207-13.
Southey MC, Tesoriero A, Young MA, Holloway AJ, Jenkins MA, Whitty J, Misfud S, kConFab, McLachlan SA, Venter DJ, Armes JE. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1. Hum Mutat 2003;22:86-91.
Staples MP, Giles GG, English DR, McCredie MR, Severi G, Cui JS, Hopper JL. Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control 2003;14:161-6.
Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken J, Giles GG, Armstrong BK. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer 2003;105:117-22.
Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N, Simpson J, (International Artemisinin Study Group). Artesunate combinations for treatment of malaria: meta-analysis. Lancet 2004;363:9-17.
Asia Pacific Cohort Studies Collaboration; Patel A, Barzi F, Jamrozik K, Lam TH, Ueshima H, Whitlock G, Woodward M. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 2004;110:2678-86.
Autier P, Boniol M, Severi G, Pedeux R, Grivegnee AR, Dore JF. Sex differences in numbers of nevi on body sites of young European children: implications for the etiology of cutaneous melanoma. Cancer Epidemiol Biomarkers Prev 2004;13:2003-5.
Ball K, Mishra GD, Thane CW, Hodge A. How well do Australian women comply with dietary guidelines? Public Health Nutr 2004;7:443-52.
Decensi A, Bonanni B, Baglietto L, Guerrieri-Gonzaga A, Ramazzotto F, Johansson H, Robertson C, Marinucci I, Mariette F, Sandri MT, Daldoss C, Bianco V, Buttarelli M, Cazzaniga M, Franchi D, Cassano E, Omodei U.A two-by-two factorial trial comparing oral with transdermal estrogen therapy and fenretinide with placebo on breast cancer biomarkers. Clin Cancer Res 2004;10:4389-97.
English DR, Del Mar C, Burton RC. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust 2004;180:16-9.
English DR, MacInnis RJ, Hodge AM, Hopper JL, Haydon AM, Giles GG. Red meat, chicken, and fish consumption and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1509-14.
Gaff CL, Aragona C, MacInnis RJ, Cowan R, Payne C, Giles GG, Lindeman GJ. Accuracy and completeness in reporting family history of prostate cancer by unaffected men. Urology 2004;63:1111-6.
Giles GG, Severi G, English DR, Hopper JL. Frequency of ejaculation and risk of prostate cancer [letter] JAMA, vol. 292, 2004:329; author reply 29.
Giles GG, Thursfield V. Cancer statistics: everything you wanted to know about cancer registry data but were afraid to ask. ANZ J Surg 2004;74(11):931-4.
Giles GG. Epidemiology of food and disease: The Melbourne Cohort Study. Asia Pac J Clin Nutr. 2004;13(suppl):S30.
Giles-Corti B, English DR, Costa C, Milne E, Cross D, Johnston R. Creating SunSmart schools. Health Educ Res 2004;19:98-109.
Hodge AM, English DR, McCredie MR, Severi G, Boyle P, Hopper JL, Giles GG. Foods, nutrients and prostate cancer. Cancer Causes Control 2004;15:11-20.
Hodge AM, English DR, O'Dea K, Giles GG. Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care 2004;27:2701-6.
Hodge AM, English DR, O'Dea K, Giles GG. Increased diabetes incidence in Greek and Italian migrants to Australia: how much can be explained by known risk factors? Diabetes Care 2004;27:2330-4.
Hurley SF, Scollo MM, Younie SJ, English DR, Swanson MG. The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease. Med J Aust 2004;181:252-5.
Johansson H, Baglietto L, Guerrieri-Gonzaga A, Bonanni B, Mariette F, Macis D, Serrano D, Teresa Sandri M, Decensi A. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Res Treat 2004;88:63-73.
Keogh LA, Maskiell J, Southey MC, Young MA, Gaff CL, Kirk J, Tucker KM. Uptake of offer to receive genetic information about BRCA1 and BRCA2 in a population-based study. Cancer Epidemiol Biomarkers Prev 2004;13:2258-63.
Lee C, Rowley K, Jenkins A, O'Dea K, Itsiopoulos C, Stoney RM, Su Q, Giles GG, Best J. Paraoxonase activity in Greek migrants and Anglo-Celtic persons in the Melbourne Collaborative Cohort Study: relationship to dietary markers. Eur J Nutr 2004;12:1-8.
Macinnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:2117-25.
MacInnis RJ, English DR, Hopper JL, Haydon AM, Gertig DM, Giles GG. Body size and composition and colon cancer risk in men. Cancer Epidemiol Biomarkers Prev 2004;13:553-9.
MacInnis RJ, English DR. Making the most of cohort studies: Choosing between case-cohort and nested case-control designs. [Not refereed] Australasian Epidemiologist, vol. 11, 2004:26-29.
Mitchell AE, Scarcella DL, Rigutto GL, Thursfield VJ, Giles GG, Sexton M, Ashley DM. Cancer in adolescents and young adults: treatment and outcome in Victoria. Med J Aust 2004;180:59-62.
Morgan T, Anderson A, Bertram D, MacInnis RJ. Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria. J Renin Angiotensin Aldosterone Syst 2004;5:64-71.
Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, Giles GG, Hopper JL. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. J Clin Oncol 2004;22:699-705.
Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study. Pathology 2004;36:221-9.
Richardson AK, Cox B, McCredie MR, Dite GS, Chang JH, Gertig DM, Southey MC, Giles GG, Hopper JL. Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer 2004;90:2149-52.
Vajdic CM, Kricker A, Giblin M, McKenzie J, Aitken JF, Giles GG, Armstrong BK. Artificial ultraviolet radiation and ocular melanoma in Australia. Int J Cancer 2004;112:896-900.
White V, Pruden M, Giles G, Collins J, Jamrozik K, Inglis G, Boyages J, Hill D. The management of early breast carcinoma before and after the introduction of clinical practice guidelines. Cancer 2004;101:476-85.
Asia Pacific Cohort Studies Collaboration. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil. 2005;12:484-91.
Asia Pacific Cohort Studies Collaboration. Does Sex Matter in the Association between Classical Risk Factors and Fatal Coronary Heart Disease? J Women's Health (Larchmt) 2005;14:820-8.
Asia Pacific Cohort Studies Collaboration; Huxley R, Barzi F, Stolk R, Caterson I, Gill T, Lam TH, Omari A, Woodward M. Ethnic comparisons of obesity in the Asia-Pacific region: protocol for a collaborative overview of cross-sectional studies. Obes Rev 2005;6:193-8.
Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation 2005;112:3384-90.
Autier P, Severi G, Boniol M, de Vries E, Coebergh JW, Dore JF. Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:1159; author reply 59-60.
Baglietto L, English DR, Gertig DM, Hopper JL, Giles GG. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. Bmj 2005;331:807.
Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol 2005;141:998-1006.
Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P, Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW, Chignol MC, Dore JF, Autier P. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer 2005;41:2141-9.
Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res 2005;7:R513-21.
Coyne T, Ibiebele TI, McNaughton S, Rutishauser IHE, O'Dea K, Hodge AM, McClintock C, Findlay MG, Lee A. Evaluation of brief dietary questions to estimate vegetable and fruit consumption - using serum carotenoids and red-cell folate. Public Health Nutr 2005;8:305-15.
de Vries E, Boniol M, Severi G, Eggermont AM, Autier P, Bataille V, Dore JF, Coebergh JW. Public awareness about risk factors could pose problems for case-control studies: The example of sunbed use and cutaneous melanoma. Eur J Cancer 2005;41:2150-4.
Dite GS, Wark JD, Giles GG, English DR, McCredie MR, Hopper JL. Is there overlap between the genetic determinants of mammographic density and bone mineral density? Cancer Epidemiol Biomarkers Prev 2005;14:2266-8.
English DR, Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R. The effect of a school-based sun-protection intervention on the development of melanocytic nevi in children: six-year follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:977-80.
English DR, Milne E, Simpson JA. Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev 2005;14:2873-6.
Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Ward JD. Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trail. J Am Geriatr Soc 2005;53:1881-8.
Frydenberg M, Millar JL, Toner G, Bolton D, Syme R, Thursfield VJ, Giles GG. Management of superficial bladder cancer in Victoria: 1990 and 1995. ANZ J Surg 2005;75:270-4.
Giles GG. Medical record linkage in Australia: this is as good as it gets. ANZ J Surg 2005;75:259.
Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev 2005;14:993-6.
Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG. Genetic variants in the vitamin D receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:997-9.
Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Stevens M, Houlston RS, Engert J, Sinnett D, Simard J, Heimdahl K, Moller P, Badzioch M, Eeles RA, The Cancer Research UK/British Association of Urological Surgeons' Section of Oncology Collaborators, Easton DF, English DR, Hopper JL, Foulkes WD, Giles GG. Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer. Cancer Epidemiol Biomarkers Prev 2005;14:397-402.
Hopper JL, Hayes VM, Spurdle AB, Chenevix-Trench G, Jenkins MA, Milne RL, Dite GS, Tesoriero AA, McCredie MR, Giles GG, Southey MC. A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer. Hum Mutat 2005;26:298-302.
Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schonitzer D, Severi G, Robertson C, Boyle P, Bartsch G. Screening for prostate cancer: updated experience from the Tyrol study. Can J Urol 2005;12 Suppl 1:7-13; discussion 92-3.
Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1828-31.
Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1686-91.
MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 2005;97:1154-7.
Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Oral Contraceptive Use and Risk of Early-Onset Breast Cancer in Carriers and Noncarriers of BRCA1 and BRCA2 Mutations. Cancer Epidemiol Biomarkers Prev 2005;14:350-6.
Mishra G, Ball K, Patterson A, Brown W, Hodge A, Dobson A. Socio-demographic inequalities in the diets of mid-aged Australian women. Eur J Clin Nutr 2005;59:185-95.
Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women. Breast Cancer Res 2005;7:R353-6.
Orlando L, Renne G, Rocca A, Curigliano G, Colleoni M, Severi G, Peruzzotti G, Cinieri S, Viale G, Sanna G, Goldhirsch A. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. Ann Oncol 2005;16:1094-9.
Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, Manoukian S, Radice P, van der Luijt RB, van Nesselrooij BP, Chenevix-Trench G, kConFab, Caldes T, de la Hoya M, Lindquist S, Tavtigian SV, Goldgar D, Borg A, Narod SA, Monteiro AN. Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet 2005;42:138-46.
Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL. Agreement Between Self-Reported Breast Cancer Treatment and Medical Records in a Population-Based Breast Cancer Family Registry. J Clin Oncol 2005;23:4679-86.
Schaid DJ, Chang BL. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. Prostate 2005;63:276-90.
Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, Arslan A, Ahlbom A, Giles GG, Howe GR, Menegoz F, Rodvall Y, Choi W, Wahrendorf J. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. Int J Cancer 2005;113:116-25.
Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A. Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer. Clin Cancer Res 2005;11:2083-8.
Simpson JA, MacInnis RJ, English DR, Gertig DM, Morris HA, Giles GG. A comparison of estradiol levels between women with a hysterectomy and ovarian conservation and women with an intact uterus. short communication 2005;8:300-3.
Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John JB, Macrae FA, Giles GG, Hopper JL. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005;23:6524-32.
Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, Hopper JL, Chenevix-Trench G, Easton DF. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005;7:R176-83.
Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G. Two ATM variants and breast cancer risk. Hum Mutat 2005;25:594-5.
Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 2005;14:319-23.
Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh C, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD,. Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Suzanne Kolb S, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai C, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLJ, Maier C, Herkommer K, Hoegel J, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Grönberg H, Camp NJ, Farnham J, Cannon Albright L, Seminara D. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet 2005;77:219-29.
Aghmesheh M, Suo Z, Friedlander M, Nesland JM, Kaern J, Stewart M, KConfab, Dorum A, Tucker KM, Buckley MF. Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas. Pathology. 2006 Apr;38(2):145-51
Alsop K, Mead L, Smith D, Royce SG, Tesoriero AA, Young JP, Haydon A, Grubb G, Giles GG, Jenkins MA, Hopper JL, Southey MC. Low somatic K-RAS mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer. 2006 Jul;42(10):1357-61
Asia Pacific Cohort Studies Collaboration, Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, Gu DF, Woodward M. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tob Control 2006;15:181-8.
Asia Pacific Cohort Studies Collaboration. An evaluation of metabolic risks for coronary death in the Asia Pacific Region. Diabetes Research and Clinical Practice 74(2006); 274-281.
Asia Pacific Cohort Studies Collaboration. Central obesity and cardiovascular in the Asia Pacific region. Asia Pac J Clin Nutrition 2006; 15(3): 287-292.
Asia Pacific Cohort Studies Collaboration. Coronary risk prediction for those with and without diabetes. Eur J Cardiovasc Prev Rehabil. 2006;13(1):30-36.
Asia Pacific Cohort Studies Collaboration. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006 Jan 14;332(7533):73-8.
Asia Pacific Cohort Studies Collaboration. Central obesity and cardiovascular disease in the Asia Pacific region. Asia Pac J Clin Nutri. 2006;15:287-92.
Asia Pacific Cohort Studies Collaboration. Body mass index and the risk of diabetes mellitus in the Asia-Pacific region. Asia Pac J Clin Nutr. 2006;15:127-33.
Asia Pacific Cohort Studies Collaboration. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. Tobacco Control 2006 Jun;15(3):181-8.
Asia Pacific Cohort Studies Collaboration. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-pacific region. Cancer Epidemiol Biomakers Prev 2006; 15:2435-40.
Asia Pacific Cohort Studies Collaboration. An evaluation of metabolic risks for coronary death in the Asia Pacific region. Diabetes Res Clin Pract. 2006;74:7274-81.
Asia Pacific Cohort Studies Collaboration. Coronary risk prediction among individuals with and without diabetes. Eur J Cardiov Prev Rehab. 2006;13:30-6.
Asia Pacific Cohort Studies Collaboration. The impact of cardiovascular risk factors on the age related excess risk of coronary heart disease. Int J Epidemiol. 2006;35:1025-33.
Baade PD, English DR, Youl PH, McPherson M, Elwood JM, Aitken JF. The relationship between melanoma thickness and time to diagnosis in a large population-based study. Arch Dermatol. 2006 Nov;142(11):1422-7
Baglietto L, English DR, Hopper JL, Powles J, Giles GG. Average volume of alcohol consumed, type of beverage, drinking pattern and the risk of death from all causes. Alcohol Alcohol. 2006 Nov-Dec;41(6):664-71.
Baglietto L, Jenkins MA, Severi G, Giles GG, Bishop DT, Boyle P, Hopper JL. Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 2006 Feb;59(2):114-124.
Baglietto L, Severi G, English DR, Hopper JL, Giles GG. Alcohol consumption and prostate cancer risk: Results from the Melbourne Collaborative Cohort Study. Int J Cancer 2006 Apr;119(6):1501-4.
Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H; kConFab Investigators; Kirk JA. Histopathological features of breast cancer in carriers of ATM gene variants. Histopathology. 2006 Nov;49(5):523-32.
Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Hum Mutat. 2006 Nov;27(11):1122-8
Brinkman M, Buntinx F, Muls E, Zeegers MP. Use of selenium in chemoprevention of bladder cancer. Lancet Oncol. 2006 Sep;7(9):766-74. Review.
Brinkman M, Reulen RC, Kellen E, Buntinx F, Zeegers MP. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006 Oct;42(15):2463-71. Epub 2006 Sep 1.
Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM, Russell PJ, Giles GG, Breit SN. Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis. Clin Cancer Res. 2006 Jan 1;12(1):89-96
Cazzaniga M, Severi G, Casadio C, Chiapparini L, Veronesi U, Decensi A. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1311-5.
Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, Scholl T, Bekessy A, Marsh A, Lovelock P, Wong M, Tesoriero A, Renard H, Southey M, Hopper JL, Yannoukakos K, Brown M, Easton D, Tavtigian SV, Goldgar D, Spurdle AB; kConFab Investigators. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res. 2006 Feb 15;66(4):2019-27.
Colombo N, Formelli F, Cantu MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, et al. A Phase I-II Preoperative Biomarker Trial of Fenretinide in Ascitic Ovarian Cancer. Cancer Epidemiol Biomarkers Prev 2006;15:1914-9.
Creamer MC, Carboon I, Forbes AB, McKenzie DP, McFarlane AC, Kelsall HL, Sim MR. Psychiatric disorder and separation from military service: A 10 year retrospective study. American Journal of Psychiatry 2006; 163:733-734.
Dite GS, Wark JD, Giles GG, English DR, McCredie MRE, Hopper JL. Is there a positive association between mammographic density and bone mineral density? Breast Cancer Research 2006, 8:401. Epub 2006 Feb 13.
El Haber N, Hill KD, Cassano AM, Paton LM, MacInnis RJ, Cui JS, Hopper JL, Wark JD. Genetic and environmental influences on variation in balance performance among female twin pairs aged 21-82 years. Am J Epidemiol. 2006 Aug 1;164(3):246-56
English DR, Milne E, Simpson JA. Ultraviolet radiation at places of residence and the development of melanocytic nevi in children. Cancer Causes &Control 2006;Feb;17(1):103-7.
Farshid G, Balleine RL, Cummings M, Waring P; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol. 2006 Nov;30(11):1357-66.
Gertig DM, Fletcher AS, English DR, Macinnis RJ, Hopper JL, Giles GG. Hormone therapy and breast cancer: what factors modify the association? Menopause. 2006 March/April;13(2):178-184.
Giles GG, Simpson J, English DR, Hodge AM, Gertig D, MacInnis R, Hopper J. Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer. Int J Cancer. 2006 Apr 1;118(7):1843-7.
Glass DC, Sim MR, Kelsall HL, Ikin JF, McKenzie D, Forbes A, Ittak P. What was different about exposures reported by male Australian Gulf War veterans during the 1991 Persian Gulf War, compared with exposures reported for other deployments? Military Medicine 2006; 171:632-638.
Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G. Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol. 2006 Mar;27(1):42-5.
Guzzi G, Minoia C, Pigatto PD, Severi G. Methylmercury, amalgams, and children's health. Environ Health Perspect. 2006 Mar;114(3):A149; author reply A149-50.
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, kConFab Investigators, Ontario Cancer Genetics Network Investigators, Whittemore AS. BRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70. Epub 2006 Oct 4.
Haydon AM, MacInnis RJ, English DR, Giles GG. The effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006 Jan;55(1):62-7.
Haydon AM, Macinnis RJ, English DR, Morris H, Giles GG. Physical activity, IGF-1, IGFBP-3 and survival from colorectal cancer. Gut. 2006 May;55(5):689-94.
Hayes VM, Severi G, Southey MC, Padilla EJ, English DR, Hopper JL, Giles GG, Sutherland RL. Macrophage inhibitory cytokine-1 H6D polymorphism, prostate cancer risk, and survival. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1223-5.
Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res. 2006 Feb 15;66(4):2250-6.
Hodge AM, English DR, O'Dea K, Giles GG. Alcohol intake, consumption pattern and beverage type, and the risk of Type 2 diabetes. Diabet Med. 2006 Jun;23(6):690-7.
Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC. Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol. 2006 Apr;4(4):489-98.
Jenkins MA, Dharmage SC, Flander LB, Douglass JA, Ugoni AM, Carlin JB, Sawyer SM, Giles GG, Hopper JL. Parity and decreased use of oral contraceptives as predictors of asthma in young women. Clin Exp Allergy. 2006 May;36(5):609-613.
Jenkins MA, Macrae F, Young J, Barker M, Leggett B, Goldblatt J, Kirk J, Tucker K, Suthers G, Young G, Parry S, Arnold J, Winship I, Maskiell J, Giles G, Jass J, Hopper J. The Colon Cancer Family Registry, an international resource for studying the genetic and molecular epidemiology of colorectal cancer. Gastrointestinal Cancer Update 2006;46:14-20
49. Jennens RR, Giles GG, Fox RM. Increasing underrepresentation of elderly patients with advanced colorectal ornon-small-cell lung cancer in chemotherapy trials. Intern Med J. 2006 Apr;36(4):216-20.
Johansson H, Bonanni B, Mariette F, Cazzaniga M, Baglietto L, Guerrieri-Gonzaga A, Sandri MT, Luini A, Pelosi G, Decensi A. Effects of raloxifene on sex steroid hormones and C-telopeptide in postmenopausal women with primary breast cancer. Breast Cancer Res Treat. 2006 Jul;98(2):167-72. Epub 2006 Mar 15.
Kang HH, Williams R, Leary J; kConFab Investigators; Ringland C, Kirk J, Ward R. Evaluation of models to predict BRCA germline mutations. Br J Cancer. 2006 Oct 9;95(7):914-20.
Kelsall H, Sim M, McKenzie D, Forbes A, Leder K, Glass D, Ikin J, McFarlane A. Medically evaluated psychological and physical health of Australian Gulf War veterans with chronic fatigue. Journal of Psychosomatic Research 2006; 60:575-584.
Khanjani N, English DR, Sim MR. An ecological study of organochlorine pesticides and breast cancer in rural Victoria, Australia. Archives of Environmental Contamination and Toxicology. Arch Environ Contam Toxicol. 2006 Apr;50(3):452-61. Epub 2006 Feb 17
Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL. An inverse association between ovarian cysts and breast cancer in the breast cancer family registry. Int J Cancer. 2006 Jan 1;118(1):197-202
Lagerlund M, Dixon HG, Simpson JA, Spittal M, Taylor HR, Dobbinson SJ. Observed use of sunglasses in public outdoor settings around Melbourne, Australia: 1993 to 2002. Preventive Medicine. 2006;42:291-6.
Lose F, Lovelock P, Chenevix-Trench G, Mann GJ, Pupo GM, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Variation in the RAD51 gene and familial breast cancer. Breast Cancer Res. 2006;8(3):R26. Epub 2006 Jun 8. PMID: 16762046
Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S, Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ, Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA; kConFab Investigators. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1missense variants.J Med Genet. 2006 Jan;43(1):74-83. Epub 2005 May 27.
MacInnis R, English DR, Haydon AM, Hopper JL, Gertig DM, Giles GG. Body size and composition and risk of rectal cancer (Australia). Cancer Causes Control 2006 Dec 17(10): 1291-7.
MacInnis R, English DR, Hopper JL, Giles GG. Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer. 2006 May 15;118(10):2628-31.
MacInnis R, English DR. Body size and composition and prostate cancer risk: systematic review and meta regression analysis. Cancer Causes Control. 2006 Oct;17(8):989-1003.
MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and colon cancer in postmenopausal women. Int J Cancer. 2006 Mar 15;118(6):1496-500.
Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, Giles GG, Goldblatt J, Hopper JL, Kirk J, Leary JA, Lindeman G, Niedermayr E, Phillips KA, Picken S, Pupo GM, Saunders C, Scott CL, Spurdle AB, Suthers G, Tucker K, Chenevix-Trench G; Kathleen Cuningham Consortium for Research in Familial Breast Cancer. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res. 2006;8(1):R12. Epub 2006 Feb 13.
McGuire V, John EM, Anna Felberg A, Haile RW, Boyd NF,. Thomas DC, Jenkins MA, Milne RL, Daly MB, J Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, kConFab Investigators, Southey M, West DW, Hopper JL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations under age 50 years. Cancer Epidemiol Biomarkers Prev 2006 Aug;15(8):1565-7.
McKenzie DP, McFarlane AC, Creamer M, Ikin JF, Forbes AB, Kelsall HL, Clarke DM, Glass DC, Ittak P, Sim MR. Hazardous or harmful alcohol use in Royal Australian Navy veterans of the 1991 Gulf War: Identification of high risk subgroups. Addictive Behaviors 2006; 31:1683-1694.
McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. Journal of the American Academy of Dermatology. 2006;54(5):783-92.
Millar JL, Frydenberg M, Toner G, Syme R, Thursfield V, Giles GG; Urology Study Committee of the Victorian Co-operative Oncology Group. Management of muscle-invasive bladder cancer in Victoria, 1990-1995. ANZ J Surg. 2006 Mar;76(3):113-119.
Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R, English D. R. The impact of the kidskin sun protection intervention on summer suntan and reported sun exposure: Was it sustained? Prev Med. 2006;Jan;42(1):14-20.
Pedeux R, Sales F, Pourchet J, Kallassy M, Fayolle C, Boniol M, Severi G, Ghanem G, Nakazawa H, Autier P, Dore JF. Ultraviolet B sensitivity of peripheral lymphocytes as an independent risk factor for cutaneous melanoma. Eur. J. Cancer 2006;42:212-5.
Phillips KA, Jenkins MA, Lindeman GJ, McLachlan SA, McKinley JM, Weideman PC, Hopper JL, Friedlander ML; kConFab Investigators. Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study. Clin Genet. 2006 Sep;70(3):198-206.
Robman L, Vu H, Hodge A, McCarty CA, Taylor HR. Dietary lutein and zeaxanthin: authors' response. Br J Ophthalmol. 2006 Sep;90(9):1211-2.
Rosenthal MA, Drummond KJ, Dally M, Murphy M, Cher L, Ashley D, Thursfield V, Giles GG. Management of glioma in Victoria (1998-2000): retrospective cohort study. Med J Aust. 2006 Mar 20;184(6):270-3.
Schaid DJ; Investigators of the International Consortium for Prostate Cancer Genetics. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet. 2006 Nov;120(4):471-85. Epub 2006 Aug 25
Scurrah KJ, Byrnes GB, Hopper JL, Harrap SB. Sex differences in genetic and environmental determinants of pulse pressure. Genet Epidemiol. 2006 Jul;30(5):397-408.
Severi G, English DR, Hopper JL, Giles GG. Prospective Studies of Dairy Product and Calcium Intakes and Prostate Cancer Risk: A Meta-Analysis. J Natl Cancer Inst 2006; 98: 795.
Severi G, Hayes VM, English DR, Hopper JL, Sutherland RL, Giles GG. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):610-2.
Severi G, Hayes VM, Neufing P, Padilla EJD, Tilley W, Eggleton S, Morris H, English D, Southey M, Hopper JL, Sutherland RL, Boyle P, Giles GG. Variants in the Prostate-Specific Antigen (PSA) Gene, and Prostate Cancer Risk, Survival, and Circulating PSA. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1142-7
Severi G, Morris H, MacInnis R, English D, Tilley W, Hopper J, Boyle P, Giles GG. Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):86-91.
Severi G, Morris H, MacInnis R, English D, Tilley W, Hopper J, Boyle P, Giles GG. Circulating insulin-like growth factor-1 and binding protein-3 and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1137-41.
Siahpush M, English D, Powles J. The contribution of smoking to socio-economic differentials in mortality: Results from the Melbourne Collaborative Cohort Study, Australia. J Epidemiol Community Health. 2006 Dec;60(12):1077-9.
Sim M, Kelsall H. Gulf War illness: a view from Australia. Philosophical Transactions of The Royal Society. 2006;361:619-626.
Simpson JA, Hughes D, Manyando C, Bojang K, Aarons L, Winstanley P, Edwards G, Watkins WA, Ward S. Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone. Br J Clin Pharmacol. 2006; 61(3): 289-300
Smith L, Tesoriero A, Mead L, Royce S, Grubb G, Young J, Giles G, Jenkins M, Macrae F, Hopper JL, Southey MC. Large genomic alterations in hMSH2 and hMLH1 in early onset colorectal cancer: identification of a large complex de novo hMLH1 alteration. Clin Genet 2006: 70: 250-252. (letter to the Editor)
Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, kConFab Investigators, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, Hopper JL, Giles GG, Buys S, Andrulis I, Senie R, BCFS, BRCAX Collaborators group, Goldgar DE, Oldenburg R, Kroeze-Jansema K, Kraan J, Meijers-Heijboer H, Klijn JGM, van Asperen C, van Leeuwen I, Vasen HFA, Cornelisse CJ, Devilee P, Baskcomb L, Seal S, Barfoot R, Mangion J, Hall A, Edkins S, Rapley E, Wooster R, Chang-Claude J, Eccles D, Evans DG, Futreal PA, Nathanson KL, Weber BL, the Breast Cancer Susceptibility Collaboration (UK), Rahman N, Stratton MR. A Genome Wide Linkage Search For Breast Cancer Susceptibility Genes. Genes Chromosomes Cancer 2006;45:646-655.
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, Santella RM, Hopper JL, John EM, Andrulis IL, Durocher F, Struewing JP, Easton DF, Chenevix-Trench G; Australian Breast Cancer Family Study, Australian Jewish Breast Cancer Study,Breast Cancer Family Registry, Interdisciplinary Health Research International Team on Breast Cancer Susceptibility, The Kathleen Cunningham Foundation Consortium for Research into Familial Breast Cancer, and Epidemiological Study of Familial Breast Cancer Study Collaborators. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):76-9
Staples M, Elwood M, Burton R, Williams J, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006; Jan 2;184(1):6-10
Stone J, Dite GS, Gunasekara A, English DR, McCredie MR, Giles GG, Cawson JN, Hegele RA, Chiarelli AM, Yaffe MJ, Boyd NF, Hopper JL. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):612-7.
Vrijheid M, Cardis E, Armstrong BK, Auvinen A, Berg G, Blaasaas KG, Brown J, Carroll M, Chetrit A, Christensen HC, Deltour I, Feychting M, Giles GG, Hepworth SJ, Hours M, Iavarone I, Johansen C, Klaeboe L, Kurttio P, Lagorio S, Lonn S, McKinney PA, Montestrucq L, Parslow RC, Richardson L, Sadetzki S, Salminen T, Schuz J, Tynes T, Woodward A; Interphone Study Group. Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med. 2006 Apr;63(4):237-43.
Vu HT, Robman L, Hodge A, McCarty CA, Taylor HR. Lutein and zeaxanthin and the risk of cataract: the Melbourne visual impairment project. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3783-6.
Vu HTV, Robman L, McCarty CA, Taylor HR, Hodge A. Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. (Letter) Br J Ophthalmol. 2006; 90:389-90.
Waddell N, Jonnalagadda J, Marsh A, Grist S, Jenkins M, Hobson K, Taylor M, Lindeman GJ, Tavtigian SV, Suthers G, Goldgar D, Oefner PJ; kConFab Investigators; Taylor D, Grimmond S, Khanna KK, Chenevix-Trench G. Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling. Genes Chromosomes Cancer. 2006 Dec;45(12):1169-81.
Wharton CL, Dharmage SC, Jenkins MA, Dite GS, Giles GG, Abramson MJ, Walters EH, Hopper JL. Tracing 8,600 participants 36 years after recruitment at age 7 for the Tasmanian Asthma Study. Aust N Z J Public Health. 2006 Apr;30(2):105-10.
White V, Pruden M, Giles G, Kitchen P, Collins J, Inglis G, Hill D. Changes in the management of ductal carcinoma in situ before the release of clinical practice recommendations in Australia: the case in Victoria. ANZ J Surg. 2006 Jan;76(1-2):28-34.
Woodward M, Barzi F, Martiniuk A, Fang X, Gu D, Imai Y, Lam T, Pan W, Rodgers A, Suh I, Jee Sh, Ueshima H, Huxley R. Cohort profile: the Asia Pacific Cohort Studies Collaboration. Int J Epidemiol. 2006 Dec 35 (6): 1412-6 Epub 2006. Oct 22.
2007
Allen KJ, Gurrin LC, Constatine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Fletcher AS, Nisselle AE, Forrest S, Vulpe CD, Anderson GJ, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. A Prospective Study of Mutations in the HFE Gene and Development of Hereditary Hemochromatosis Disease. accepted for publication in the New England Journal of Medicine 17 Oct 07
Antoniou AC, Sinilnikova OM, Simard J, Leone M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ; Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers Study (GEMO), Rebbeck TR, Wagner T, Lynch HT, Domchek SM, Nathanson KL, Garber JE, Weitzel J, Narod SA, Tomlinson G, Olopade OI, Godwin A, Isaacs C, Jakubowska A, Lubinski J, Gronwald J, Gorski B, Byrski T, Huzarski T, Peock S, Cook M, Baynes C, Murray A, Rogers M, Daly PA, Dorkins H; Epidemiological Study of BRCA1 and BRCA2 Mutation Carriers (EMBRACE), Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Niederacher D, Deissler H; GermanConsortium for Hereditary Breast and Ovarian Cancer (GCHBOC), Spurdle AB, Chen X, Waddell N, Cloonan N; Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Kirchhoff T, Offit K, Friedman E, Kaufmann B, Laitman Y, Galore G, Rennert G, Lejbkowicz F, Raskin L, Andrulis IL, Ilyushik E, Ozcelik H, Devilee P, Vreeswijk MP, Greene MH, Prindiville SA, Osorio A, Benitez J, Zikan M, Szabo CI, Kilpivaara O, Nevanlinna H, Hamann U, Durocher F, Arason A, Couch FJ, Easton DF, Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1/2(CIMBA). RAD51 135G-->C Modifies Breast Cancer Risk among BRCA2 Mutation Carriers: Resultsfrom a Combined Analysis of 19 Studies. Am J Hum Genet. 2007 Dec;81(6):1186-200. Epub 2007 Oct 16.
Asia Pacific Cohort Studies Collaboration. Hypertension: its prevalence and population attributable fraction for mortality form cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007 Jan;25(1):73-9.
Asia Pacific Cohort Studies Collaboration. Impact of smoking and smoking cessation on lung cancer mortality in the Asia-Pacific Region: The Asia Pacific Cohort Studies Collaboration. Am J Epidemiol. 2007 Jun 1;165(11):1280-6
Asia Pacific Cohort Studies Collaboration. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. Asia Pac J Clin Nutr 2007;1691):187-92.
Asia Pacific Cohort Studies Collaboration. Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South East Asia and Western Pacific regions. Asia Pac J Clin Nutr. 2007;16(1):187-92
Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):763-8.
Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles GG, Godwin AK, Hisbshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, Southey MC, West DW, Whittemore AS, Wu H, Andrulis IL, O'Malley FP for the Breast Cancer Family Registry. BRCA2 Mutation-Associated Breast Cancers Exhibit a Distinguishing Phenotype Based on Morphology and Molecular Profiles from Tissue Microarrays. Am J Surg Pathol 2007 Jan;31(1):121-8.
Baranyay FJ, Wang Y, Wluka AE, English DR, Giles GG, Sullivan RO, Cicuttini FM. Association of Bone Marrow Lesions with Knee Structures and Risk Factors for Bone Marrow Lesions in the Knees of Clinically Healthy, Community-Based Adults. Semin Arthritis Rheum. 2007 Oct;37(2):112-8. Epub 2007 Mar 27.
Bernsen RM, van der Wouden JC, Dharmage SC, Matheson M, Nakajima K, Carlin JB, Wharton C, Jenkins MA, Giles G, Hopper J, Walters EH, Abramson M. Is childhood immunisation associated with atopic disease from age 7 to 32 years? Thorax. 2007 Oct;62(10):925-6.
Burgess JA, Walters EH, Byrnes GB, Giles GG, Jenkins MA, Abramson MJ, Hopper JL, Dharmage SC. Childhood adiposity predicts adult onset asthma in females: a 25 year prospective study. Eur Respir J. 2007 29:668-675.
Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AG, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International consortium for prostate cancer genetics. Hum Mol Genet. 2007 Jun 1;16(11):1271-8.
Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C, Kilkenny M, McKinney P, Modan B, Sadetzki S, Schuz J, Swerdlow A, Vrijheid M, Auvinen A, Berg G, Blettner M, Bowman J, Brown J, Chetrit A, Christensen HC, Cook A, Hepworth S, Giles GG, Hours M, Iavarone I, Jarus-Hakak A, Klaeboe L, Krewski D, Lagorio S, Lonn S, Mann S, McBride M, Muir K, Nadon L, Parent ME, Pearce N, Salminen T, Schoemaker M, Schlehofer B, Siemiatycki J, Taki M, Takebayashi T, Tynes T, van Tongeren M, Vecchia P, Wiart J, Woodward A, Yamaguchi N. The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647-64. Epub 2007 Jul 18.
Cazzaniga M, Severi G, Casadio C, Chiapparini L, Veronesi U, Decensi A. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1311-5.
Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, Scollen S, Baynes C, Ponder BA, Chanock S, Lissowska J, Brinton L, Peplonska B, Southey MC, Hopper JL, McCredie MR, Giles GG, et al; on behalf of the Breast Cancer Association Consortium. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet. 2007 Mar;39(3):352-8. Epub 2007 Feb 11.
Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R, Wareham N, Ahmed S, Healey CS, Bowman R; SEARCH collaborators, Meyer KB, Haiman CA, Kolonel LK, Henderson BE, Le Marchand L, Brennan P, Sangrajrang S, Gaborieau V, Odefrey F, Shen CY, Wu PE, Wang HC, Eccles D, Evans DG, Peto J, Fletcher O, Johnson N, Seal S, Stratton MR, Rahman N, Chenevix-Trench G, Bojesen SE, Nordestgaard BG, Axelsson CK, Garcia-Closas M, Brinton L, Chanock S, Lissowska J, Peplonska B, Nevanlinna H, Fagerholm R, Eerola H, Kang D, Yoo KY, Noh DY, Ahn SH, Hunter DJ, Hankinson SE, Cox DG, Hall P, Wedren S, Liu J, Low YL, Bogdanova N, Schurmann P, Dork T, Tollenaar RA, Jacobi CE, Devilee P, Klijn JG, Sigurdson AJ, Doody MM, Alexander BH, Zhang J, Cox A, Brock IW, MacPherson G, Reed MW, Couch FJ, Goode EL, Olson JE, Meijers-Heijboer H, van den Ouweland A, Uitterlinden A, Rivadeneira F, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Hopper JL, McCredie M, Southey M, Giles GG, Schroen C, Justenhoven C, Brauch H, Hamann U, Ko YD, Spurdle AB, Beesley J, Chen X; kConFab; AOCS Management Group, Mannermaa A, Kosma VM, Kataja V, Hartikainen J, Day NE, Cox DR, Ponder BA. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007 Jun 28;447(7148):1087-93.
Guzzi G, Pigatto PD, Severi G. Oral cancer: an association with dental metal restorations and allergy to metals? Int J Dermatol. 2007 Aug;46(8):885; author reply 885-6.
Guzzi G, Pigatto PD, Pallotti F, Severi G. Mercury in amalgam tattoos. Micron. 2007;38(6):694-5; author reply 696. Epub 2007 Feb 3.
19. Hammet F, George J, Tesoriero AA, Jenkins MA, Schroen C, Smith L, Grabosch-Meehan A, Dite G, McCredie MR, Giles GG, Tavtigian SV, Hopper JL, Southey MC. Is BRCA2 c.9079 G > A a predisposing variant for early onset breast cancer? Breast Cancer Res Treat. 2007 Jun 5; [Epub ahead of print]
Harriss LR, English DR, Powles J, Giles GG, Tonkin AM, Hodge AM, Brazionis L, O'Dea K. Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study. Am J Clin Nutr. 2007 Jul;86(1):221-9.
Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer. 2007 Feb 15;120(4):776-80.
Hayes VM, Severi G, Padilla EJ, Morris HA, Tilley WD, Southey MC, English DR, Sutherland RL, Hopper JL, Boyle P, Giles GG. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia. Int J Cancer. 2007 Feb 15;120(4):776-80.
Hodge AM, English DR, O'Dea K, Sinclair A, Makrides M, Gibson R, Giles GG. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr. 2007 Jul;86(1):189-97.
Hodge AM, English DR, O'dea K, Giles GG. Dietary Patterns and Diabetes Incidence in the Melbourne Collaborative Cohort Study. Am J Epidemiol. 2007 Mar 15;165(6):603-10. Epub 2007 Jan 12.
Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, O'Dea K, English DR, Giles GG. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutrition, Metabolism & Cardiovascular Diseases 2007;17:415-426.
Jefford M, Jennens R, Speer T, Thursfield V. Different professionals knowledge and perceptions of the management of people with pancreatic cancer. Asia-pacific Journal of clinical Oncology 2007;3: 44-51.
Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and Approach to, -Studying Modifiers of Risk in -Persons with a Genetic Predisposition to Colorectal Cancer. Curr Oncol Rep. 2007 May;9(3):202-207
Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR; Colon Cancer Family Registry. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007 Jul;133(1):48-56. Epub 2007 Apr 25.
Johansson H, Gandini S, Bonanni B, Mariette F, Guerrieri-Gonzaga A, Serrano D, Cassano E, Ramazzotto F, Baglietto L, Sandri MT, Decensi A. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women. Breast Cancer Res Treat. 2007 Apr 28; [Epub ahead of print]
John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, Andrulis IL, Southey M, Giles GG, West DW, Whittemore AS. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer. 2007 Jul 15;121(2):386-94.
Karipidis K, Benke G, Sim MR, Yost M, Giles GG. Occupational exposure to low frequency magnetic fields and the risk of low grade and high grade glioma. Cancer Causes Control. 2007 Apr;18(3):305-13. Epub 2007 Jan 27.
Karipidis K, Benke G, Sim M, Kauppinen T, Giles GG. Occupational exposure to ionising and non-ionizing radiation and risk of glioma. Occupational Medicine 2007 Oct;57(7):518-24. Epub 2007 Aug 29.
Kelly J, Henderson MA, Thursfield V, Slavin J, Ainslie J, Giles GG. The management of primary cutaneous melanoma in Victoria in 1996 and 2000. Med J Aust. 2007 Nov 5;187(9):511-4.
Lee JE, Hunter DJ, Spiegelman D, Adami HO, Bernstein L, van den Brandt PA, Buring JE, Cho E, English D, Folsom AR, Freudenheim JL, Giles GG, Giovannucci E, Horn-Ross PL, Leitzmann M, Marshall JR, Mannisto S, McCullough ML, Miller AB, Parker AS, Pietinen P, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ, WillettWC, Wolk A, Zhang SM, Smith-Warner SA. Intakes of coffee, tea, milk, soda, and juice and renal cell cancer in a pooled analysis of 13 prospective studies. Int J Cancer. 2007; 15;121(10) 2246-53.
Lovelock PK, Wong EM, Sprung CN, Marsh A, Hobson K, French JD, Southey M, Sculley T, Pandeya N, Brown MA, Chenevix-Trench G, Spurdle AB, McKay MJ; kConFab Investigators. Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability. Breast Cancer Res Treat. 2007 Sep;104(3):257-66. Epub 2006 Oct 25.
Mead LJ, Jenkins MA, Young J, Royce SG, Smith L, St John DJ, Macrae F, Giles GG, Hopper JL, Southey MC. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res. 2007 May 15;13(10):2865-9.
Meiser B, Cowan R, Costello A, Giles GG, Lindeman GJ, Gaff GL. Prostate cancer screening amongst men with a family history of prostate cancer: The role of partners in influencing men's screening uptake. Urology. 2007 Oct;70(4):738-42
Minoia C, Ronchi A, Gaggeri R, Guzzi G, Severi G. Correlating blood mercury and dental amalgams. Sci Total Environ. 2007 Aug 1;381(1-3):331; author reply 332. Epub 2007 Mar 28
Milne E, Simpson JA, Johnston R, Giles-Corti B, English DR. Time spent outdoors at midday and children's body mass index. Am J Public Health. 2007 Feb;97(2):306-10. Epub 2006 Dec 28.
Nakajima K, Dharmage SC, Carlin JB, Wharton CL, Jenkins MA, Giles GG, Abramson MJ, Haydn Walters E, Hopper JL. Is childhood immunisation associated with atopic disease from age 7 to 32 years? Thorax. 2007 Mar;62(3):270-5. Epub 2006 Nov 7.
Pigatto PD, Guzzi G, Severi G. Metals, orthopaedic implants, and risk of cancer. Lancet. 2007 Apr 7;369(9568):1168.
Racunica TL, Szramka M, Wluka AE, Wang Y, English DR, Giles GG, O'sullivan R, Cicuttini FM. A positive association of smoking and articular knee joint cartilage in healthy people. Osteoarthritis Cartilage. 2007 May;15(5):587-90
Racunica TL, Teichtal AJ, Wang Y, Wluka AE, English DR, Giles GG, O'Sullivan R, Cicutinni FM. Effect of physical activity on articular knee joint structures in community-based adults. Arthritis Rheum. 2007 Sep 28;57(7):1261-1268 [Epub ahead of print]
Saunders IW, Hannan GN, Brohede J, Giles GG, Jenkins MA, Hopper JL, Southey MC. A range of simple summary genome-wide statistics for detecting genetic linkage using high-density marker data. Genet Epidemiol. 2007 Apr 18; [Epub ahead of print]
Severi G, Hayes VM, Padilla EJ, English DR, Southey MC, Sutherland RL, Hopper JL, Giles GG. The Common Variant rs1447295 on Chromosome 8q24 and Prostate Cancer Risk: Results from an Australian Population-Based Case-Control Study. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):610-2.
Severi G, Hayes VM, Tesoriero AA, Southey MC, Hoang HN, Padilla EJ, Morris HA, English DR, Sutherland RL, Boyle P, Hopper JL, Giles GG. The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels. BJU Int. 2007 Nov 6; [Epub ahead of print]
Simpson JA, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG. A comparison of different methods for including ‘age at menopause' in analyses of the association between HRT use and breast cancer. Journal of Family Planning & Reproductive Healthcare 2007; 33(1): 11-16.
Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR. A comparison of adiposity measures as predictors of all case mortality: The Melbourne Collaborative Cohort Study. Obesity (Silver Spring). 2007 Apr;15(4):994-1003.
Smith LD, Tesoriero AA, Ramus SJ, Dite G, Royce SG, Giles GG, McCredie MR, Hopper JL, Southey MC. BRCA1 promoter deletions in young women with breast cancer and a strong family history: A population based study. Eur J Cancer. 2007 Mar;43(5):823-7.
Teichtahl AJ, Parkins K, Hanna F, Wluka AE, Urquhart DM, English DR, Giles GG, Cicuttini FM. The relationship between the angle of the trochlear groove and patella cartilage and bone morphology--a cross-sectional study of healthy adults. Osteoarthritis Cartilage. 2007 Oct;15(10):1158-62. Epub 2007 Apr 27.
Torrisi R, Colleoni M, Veronesi P, Rocca A, Peruzzotti G, Severi G, Medici M, Renne G, Intra M, Luini A, Nole F, Viale G, Goldhirsch A. Primary therapy with ECF in combination with a GnRH analog in premenopausal women with hormone receptor-positive T2-T4 breast cancer. Breast. 2007 Feb;16(1):73-80.
Wang Y, Hodge AM, Wluka AE, English DR, Giles GG, O'Sullivan R, Forbes A, Cicuttini FM. Effects of antioxidants on knee cartliage and bone in healthy, middle aged subjects: a cross-sectional study. Arthritis Res Ther 2007 Jul 6;9(4): R66 [Epub ahead of print]
Wang Y, Wluka AE, English DR, Teichtahl AJ, Giles GG, O'Sullivan R, Cicuttini FM. Body composition and knee cartilage properties in healthy, community-based adults. Arthritis Res Ther. 2007 Jul 6;9(4):R66
Wang Y, Wluka AE, Hodge AM, English DR, Giles GG, O'sullivan R, Cicuttini FM. Effect of fatty acids on bone marrow lesions and knee cartilage in healthy, middle-aged subjects without clinical knee osteoarthritis. Osteoarthritis Cartilage. 2007 Oct 13; [Epub ahead of print]
White VM, English DR, Coates H, Lagerlund M, Borland R, Giles GG. Is Cancer Risk associated with anger control and negative affect? Findings from a Prospective Cohort Study. Psychosom Med 2007; 69(7):667-74.
Wluka AE, Wang Y, Forbes A, Teichtahl AJ, English DR, Giles GG, O'Sullivan RO, Cicuttini FM. Gender differences in knee structure: can these be explained by differences in body composition? (submitted)
Wong EM, Tesoriero AA, Pupo GM, KconFab; ABCFS, McCredie MR, Giles GG, Hopper JL, Mann GJ, Goldgar DE, Southey MC. Is MSH2 a breast cancer susceptibiluty gene? Fam Cancer. 2007 Oct 6; [Epub ahead of print]
Young J, Jenkins M, Parry S, Young B, Nancarrow D, English d, Giles G, Jass J. Serrated pathway colorectal cancer in the population: an alternative to the adenoma carcinoma sequence. GUT 2007; 56(10):1453-9.
Hill D, Elwood JM, English DR. Prevention of skin cancer. In: Colditz GA, ed. Cancer Prevention - Cancer Causes, vol. 3 Dordrecht: Kluwer Academic Publishers, 2004:328.
Giles G, Gonzales M. The epidemiology of brain tumours and factors in prognosis. In: Kaye AH, Laws E. Brain Tumour: an encyclopedic approach, 2nd ed. Edinburgh: Churchill Livingstone, 2000.
Hodge A, de Courten MP, Zimmet P. Obesity and type 2 diabetes mellitus. In: Bjorntorp P. International Textbook of Obesity. Chichester: John Wiley & Sons Ltd, 2001:351-64.
Elwood M, Aitken JF, English DR. Prevention and screening. In: Balch CM, Houghton AN, Sober AJ, Soong S. Cutaneous Melanoma, Fourth ed. St Louis: Quality Medical Publishing, 2003.
Giles G. Epidemiological investigation of prostate cancer. In: Russell P, Jackson P, Kingsley E. Methods in Molecular Medicine: Prostate Cancer Methods and Protocols, vol. 81. Totowa NJ: Humana Press Inc., 2003.
Giles GG, Boyle P. Tobacco and lung cancer. In: Boyle P, Gray N, Henningfield J, Seffrin J, Zatonski W. Tobacco science, policy & public health. Oxford: Oxford University Press, 2004:485-510.
Severi G, English DR. Descriptive epidemiology of skin cancer. In: Hill D, Elwood JM, English DR. Prevention of skin cancer, vol.
Giles GG, Whitfield K, Thursfield V, Cancer in Victoria 1998. The Cancer Council Victoria, 2000.
Giles GG, Whitfield K, Thursfield V, Testicular Cancer. The Cancer Council Victoria, 2000.
Giles GG, Whitfield K, Thursfield V, Staples M, Cancer in Victoria 1997. The Cancer Council Victoria, 2000.
Giles GG, Whitfield K, Thursfield V, Staples M, Prostate Cancer. The Cancer Council Victoria, 2000.
Hill D, White V, Pruden M, Giles GG, Collins J, Surgical management of breast cancer in Victoria in 1995. CBRC, ACCV, 2000.
National Breast Cancer Centre, Australasian Association of Cancer Registries, Breast Screen Australia, Commonwealth Department of Health & Aged Care, Australian Institute of Health and Welfare, Ductal carcinoma in situ. AIHW, 2000.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer in Australia 1998. AIHW - Cat. No: CAN 12, 2001.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer Survival in Australia, 2001. Part 1: National Summary Statistics. AIHW - Cat. No: CAN 13, 2001.
Giles GG, Thursfield V, Cancer in Victoria 1999. The Cancer Council Victoria, 2001.
Giles GG, Thursfield V, Trends in Cancer Mortality Australia 1910-1999. The Cancer Council Victoria, 2001.
National Breast Cancer Centre, Australasian Association of Cancer Registries, Breast Screen Australia, Commonwealth Department of Health & Aged Care, Australian Institute of Health and Welfare, Breast Cancer Size and Nodal Status, 2001.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer in Australia 1999. AIHW, 2002.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer survival in Australia 2001: Part 3: State and Territory tables. AIHW, 2002.
Clinical Governance Unit, The National Colorectal Cancer Care Survey. Australian Clinical Practice in 2000. National Cancer Control Initiative, 2002.
Giles GG, The Cancer Epidemic in Victoria. In: Health of Victorians, The Chief Health Officer's Bulletin Vol 2. No. 2. Victorian Department of Human Services, 2002.
Giles GG, Thursfield V, Breast Cancer. The Cancer Council Victoria, 2002.
Giles GG, Thursfield V, Cancer in Victoria 2000. The Cancer Council Victoria, 2002.
Giles GG, Thursfield V, Guide to the Victorian Cancer Registry. The Cancer Council Victoria, 2002.
Giles GG, Thursfield V, Lung Cancer. The Cancer Council Victoria, 2002.
Thursfield V, Giles GG, The epidemiology of prostate cancer and trends in Victoria. In: The Chief Health Officer's Bulletin Vol 2.
Victorian Department of Human Services, 2002.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer in Australia 2000. AIHW - Cat No. CAN18, 2003.
Australian Institute of Health and Welfare, Australasian Association of Cancer Registries, Cancer Survival in Australia 1992-1997: geographic categories and socio-economic status. AIHW - Cat No. 17, 2003.
English DR, Giles GG, Karavarsamis N, Thursfield V, Cancer Survival in Victoria. Relative survival for selected cancers diagnosed from 1982 to 1997 with follow-up to 1999. The Cancer Council Victoria, 2003.
Giles GG, Thursfield V, Cancer in Victoria 2001. The Cancer Council Victoria, 2003.
Giles GG, Thursfield V, Cancer in Victoria 2002. The Cancer Council Victoria, 2004.
Thursfield V, Farrugia H, Billiet D, Giles GG, Cancer in Victoria 2003. The Cancer Council Victoria, 2004.
Milne E. The effect of a school-based sun-protection intervention on sun-related behaviour and the development of melanocytic naevi in children Public Health Perth: The University of Western Australia, 2001:247.
Haydon A. Long term follow up of Victorian Oncology Patients Melbourne: Monash University, 2005.
MacInnis R. A prospective study of body size and composition and the risk of breast, prostate and colorectal cancer Melbourne: The University of Melbourne, 2005.
Staples MP. Familial prostate cancer in Australia in an era of widespread prostate-specific antigen testing: risk assessment and public health implications Public Health: Melbourne University, 2005
English DR. Insulin like growth factor 1 steroid sex hormones & risk of colorectal cancer in postmenopausal women: a case-cohort study. 37th Annual SER Meeting; 15-18 June 2004, Salt Lake City, USA.
English DR. Food and cancer: The Australian perspective: data from the Melbourne Collaborative Cohort Study (invited). Eat & Run: The First Australasian Nutrition, Physical Activity and Cancer Conference; 24-26 June 2002, Sydney.
English DR. Kidskin: An intervention to reduce sun exposure in children in Perth, Australia (invited). Fifth International Conference on Melanoma; 28 February - 3 March 2001, Venice, Italy.
English DR. Prostate cancer, acne and male pattern baldness: an Australian case-control study. American Society of Preventive Oncology (25th annual meeting); 11-13 March 2001, New York, USA.
English DR. Kidskin: an intervention to reduce sun exposure in children in Perth, Australia. American Society of Preventive Oncology (25th annual meeting); 11-13 March 2001, New York, USA.
English DR. Alcohol consumption and the risk of some common chronic diseases in the Melbourne Collaborative Cohort Study (invited). 32nd International Medical Advisory Group Conference; 17-20 October 2004, Canberra.
English DR. Recent trends in the epidemiology of melanoma in Australia (invited). Royal Australian College of Dermatologists annual scientific meeting; June 2002, Melbourne.
English DR. Diet and cancer (invited). QCF Forum; 11-12 November 2004, Brisbane, Qld.
English DR, Carlin JB, MacInnis R, Hodge A. Making the most of cohort studies (Thematic Session) (invited). Australasian Epidemiological Association Annual Meeting; 22-23 September 2003, Perth.
English DR, Giles GG. Red meat, chicken and fish consumption & risk of colorectal cancer in the Melbourne Collaborative Cohort Study. AACR International Conference on Frontiers in Cancer Prevention Research; 17 October 2002, Boston.
Giles GG. Plenary: diet and cancer (invited). 7th Biannual Behavioural Research in Cancer Control Conference; 25 June 2004, Woollongong.
Giles GG. FAMBIS: an integrated computer system meeting the needs of both central registration and clinical management of families that have an inherited predisposition to cancer. 2-4 June 2004, Madrid, Spain.
Giles GG. Sexual factors and prostate cancer. International Genetic Epidemiology Society; 2 November 2003, Los Angeles, USA.
Giles GG. Chairperson for session on Epidemiology. Inaugural Pacific Rim Breast and Prostate Cancer Meeting; 20-22 November 2003, Victor Harbor, South Australia.
Giles GG. Use them or lose them: cancer registries - opportunities and threats. COSA Annual Scientific Meeting; 28-30 November 2002, Sydney.
Giles GG. A prospective study of the risk of prostate cancer associated with fat free mass measured by bioelectric impedance. 24th Annual Meeting of the International Agency of Cancer Registries; 25-27 June 2002, Tampere, Finland.
Giles GG. Migrants to Australia: their cancer trends and their potential contribution to epidemiological research on cancer (invited). Migration & Cancer Conference Meeting US-Japan cooperative cancer research program; 6-8 November 2002, Gifu, Japan.
Giles GG. The role of epidemiology in the development and evaluation of education programs for the control of melanoma (invited). Fifth International Conference on Melanoma; 28 February - 3 March 2001, Venice, Italy.
Giles GG. Studies of the genetic epidemiology of prostate cancer in Australia (invited). kConFab & ABCFC Conference; 21 July 2001, Cairns.
Giles GG. Practical Issues with Databanks. 5th Annual Cabrini Research Day; 14 November 2001, Cabrini Hospital Auditorium.
Giles GG. Session on Hormones & Cancer (G Giles chaired session). Hormones & Cancer Meeting; 3-7 November 2000, Port Douglas, QLD.
Giles GG. Epidemiology of food and disease: The Melbourne cohort study. (INVITED). International Congress of Clinical Nutrition; 11-13 August 2004, Brisbane.
Giles GG. Diet and cancer- where's the evidence? (INVITED). Behavioural Research in Cancer Control 7th Biennial Conference; 23-25 June 2004, Newcastle, NSW.
Giles GG. Diet and cancer. 1st Pfizer Oncology Forum; 19-21 March 2004, Sydney.
Giles GG. The epidemiology of breast and prostate cancers; how to go forward? (INVITED). Australian Society for Medical Research Annual Scientific Meeting; 24 November 2003, Adelaide.
Giles GG. The current cancer control program in Australia. (INVITED). JCA/UICC joint symposium on cancer control in the Asia Pacific; 25-27 September 2003, Nagoya, Japan.
Giles GG. The Melbourne Collaborative Cohort Study- an Ageing Australian Cohort. (INVITED). Dynamic Processes in Ageing Symposium; 21-23 September 2003, Canberra.
Giles GG. Body size and composition and colon cancer risk in men. 25th Annual meeting of the International Association of Cancer Registries; 16-18 June 2003, Honolulu, USA.
Giles GG. The Melbourne Collaborative Cohort Study. (INVITED). Public Health Research: A Foundation for Victoria's Health.¾ VicHealth Public Health Research Symposium; 26-27 March 2003, Melbourne.
Giles GG. Of those who develop the habit of eating very few ever survive. (INVITED). Australian Nutrition Society Annual Scientific Meeting; 1-4 December 2002, Wollongong, NSW.
Giles GG. The consumption of foods and the risk of colorectal cancer. COSA Annual Scientific Meeting; 28-30 November 2002, Sydney, NSW.
Giles GG. New paradigm to assemble an infrastructure for genetic epidemiology studies: the Breast Cancer Family Register. 24th Annual meeting of the international Association of Cancer Registries; 25-27 June 2002, Tampere, Finland.
Giles GG. Mammographic Screening in Australia: the BreastScreen Program. (INVITED). Global Summit on Breast Cancer Screening; 3-5 June 2002, Milan, Italy,.
Giles GG. The Mediterranean Diet and Cancer.¾ (INVITED). International Olive Oil Council; November 2001, Sydney.
Giles GG. Studies of gene-environment interaction in prostate cancer. (INVITED). First ICRF Prevention and Control Scientific Meeting: The design of case-control studies of gene-environment interaction; 1-2 October 2001, Oxford, UK.
Giles GG. Epidemiology & the relationship between nutrition and cancer. (INVITED). Nutrition and Cancer Prevention in the 21st Century Workshop, The Cancer Council Australia; 5 July 2001, Adelaide.
Giles GG. The Melbourne Collaborative Cohort Study. European Conference on Nutrition and Cancer; 21-24 June 2001, Lyon France.
Giles GG. Epidemiology of Breast And Prostate Cancer. Hormones and Cancer 2000; 3-7 Nov 2000, Port Douglas.
Giles GG, Elwood M. The current cancer control program in Australia. JCA/UICC joint symposium on cancer control in Asia Pacific; 25-27 September 2003, Nagoya, Japan.
Giles GG, English DR. The Melbourne Collaborative Cohort Study. European Conference on Nutrition & Cancer; 21-24 June 2001, Lyon, Italy.
Giles GG, MacInnis R, English DR, Hopper JL, Gertig DM. Body size and composition and colon cancer risk in men. Annual meeting of the International Association of Cancer Registries; 16-18 June 2003, Honolulu, USA.
Hodge AM. Plasma phospholipid fatty acids and development of diabetes. Australasian Epidemiological Association annual scientific meeting; 11-12 October 2004, Adelaide.
Hodge AM. Increased diabetes incidence in southern european migrants: How much can be explained by known risk factors? Australasian Epidemiological Association annual scientific meeting; 22-23 September 2003, Perth.
Hodge AM. Dietary patterns in Greek and Italian migrants and Australian-born people in Melbourne: The Melbourne Collaborative Cohort Study. Eat & Run: The First Australasian Nutrition, Physical Activity and Cancer Conference; 24-26 June 2002, Sydney.
MacInnis R. A prospective study of the risk of prostate cancer associated with fat free mass measured by bioelectric impedance. Sixth International Symposium "In Vivo Body Composition Studies"; 3-5 October 2002, Rome, Italy.
MacInnis R, English DR, Gertig DM, Hopper JL, Giles GG. Body size and composition and colon cancer risk in men. Australasian Epidemiological Association Annual Meeting; 22-23 September 2003, Perth.
MacInnis RJ. Body size and composition and risk of postmenopausal breast cancer. Australasian Epidemiological Association annual scientific meeting; 10-12 October 2004, Adelaide.
Minkoff K, McArdle T, Farrugia H. Poster presentation. Familial Cancer 2004: Research and Practice (KCONFAB & AOCS & Family Cancer Clinics of Australia and New Zealand); 18-21 August 2004, Couran Cove, Qld.
Severi G. Prostate cancer model (invited). NCI workshop on risk prediction models; 20-21 May 2004, Washington DC, USA.
English D. Primary Prevention of Melanoma in Australia (INVITED), Sixth International Conference on Melanoma; 6-10 Sept 2005, Vancouver, Canada
English D. Sun protection and the development of melanocytic naevi in children, Clinical Oncological Society of Australia (COSA); 16-18 Nov 2005, Brisbane, QLD
Farrugia H. 2 presentations: (1) Proposed Victorian Cancer Outcome Network (VCON) (INVITED)
(2) Record Linkage at the Cancer Registry (INVITED), Vic Public Health Research & Educational Council (one day forum on data linkage); 2 Nov 2005, The Cancer Council Victoria, Melbourne
Farrugia H, Thursfield V and Billiet D. AACR Annual General Meeting & COSA Epidemiology Day, 16-18 Nov 2005, Brisbane, QLD
Giles GG. Diet, Lifestyle and Cancer (INVITED), Sydney University Nutrition Research Foundation Symposium; 10 May 2006, Sydney, NSW
Giles GG. EPIC Scientific Review Meeting (INVITED), 28 Jan 2005, London, UK
Giles GG. I still haven't found what I'm looking for - making use of Australian data from cancer registries (INVITED), Second Annual Pfizer Oncology Forum 22-24 July 2005, Sydney, NSW
Giles GG. IARC 41st session of the Scientific Council (INVITED - to represent Bob Thomas), 2-3 Feb 2005, Lyon, France
Giles GG. Prostate cancer (INVITED), 7th Annual Meeting of the International Association of Cancer Registries "Cancer in low resource populations"; 13 Sept 2005, Entebbe, Uganda
Giles GG. Prostate cancer: risk factors for the lethal phenotype (INVITED), 36th International Symposium of the Princess Takamatsu Cancer Research Fund. "Developments in Cancer Epidemiology"; 15 Nov 2005, Tokyo, Japan
Giles GG. Prostate Cancer: Risk factors for the lethal phenotypes (INVITED), WIP: School of Population Health; 21 June 2006, Melbourne University, VIC
Giles GG. What did we learn from the Australian Prostate Cancer Studies? (INVITED), Pacific Rim Breast Cancer and Prostate Cancer Conference; 12 April 2005, Palm Springs, USA
Giles GG and Severi G. Annual collaborators meeting of the ICPCG, 29 Mar - 1 Apr 2005, London, UK
Hodge A. Glycaemic index and health (INVITED), Food Industry; 12 May 2005, Melbourne, VIC
Hodge A. Health 2000 and diabetes (INVITED), Medical staff and Encrinologists; 24 June 2005, Austin Hospital, Melbourne, VIC
Marr G and Smith C. Workshop, 14th ASM AEA Longitudinal Studies Workshop: The Practicalities; 5 Oct 2005, Newcastle
McArdle T and Minkoff K. Familial Cancer 2005. A combined meeting of kConFab, Australian Ovarian Cancer Study, The Family Cancer Clinics of Australia and New Zealand and the ACCFS, 30 Aug - 2 Sep 2005, Couran Cove, QLD
Mok MT, Farrugia H, Billiet D and Sharp J. The Victorian Cancer Registry (VCR) now supports electronic cancer registration (also had a stand with VCR information for delegates), 25th National Conference on Health Information Management Association of Australia "See Change"; 27-29 July 2005, Geelong, VIC
Severi G. Are androgens carcinogenic for the prostate? The epidemiological perspective (INVITED - W TILLEY), Hormones & Prostate Cancer Symposium; 3 Mar 2006, Adelaide, SA
Severi G. CEC prostate program update (INVITED), ICPCGS; 17 Jan 2006, Scottsdale, Arizona, USA
Severi G. Circulating sex hormones and prostate cancer risk (INVITED), Seventh Annual Meeting of the Australian Prostate Cancer Collaboration; 21-22 Sept 2005, Sydney, NSW
Severi G. Circulating steroid hormones, markers of hormonal action and prostate cancer risk (INVITED), WIP: School of Population Health; 18 May 2006, Melbourne University, VIC
Severi G. The epidemiology of cancer (INVITED), Italian Medical Association Conference; 5 March 2005, Melbourne, VIC
Severi G. The epidemiology of cardiovascular disease (INVITED), Italian Medical Association Conference 4 March 2005, Melbourne, VIC
Severi G. The epidemiology of prostate cancer (INVITED), TCCV CISS Prostate Cancer Information Seminar; 20 May 2006, The Cancer Council Victoria, Melbourne
Severi G. Genetic association studies in cancer epidemiology: improving the quality to find true associations and decrease the number of false findings (INVITED), WIP Meeting at Melbourne University, Centre for Genetic Epidemiology; 9 June 2005, Melbourne University, VIC
Severi G. The Melbourne Collaborative Cohort Study, The Salvation Army; 9 Sept 2005, Essendon, VIC
Severi G. Methodological issues in genetic association studies (INVITED), IARC; 5 April 2005, Lyon, France
Severi G. Molecular Epidemiology: circulating steroid hormones, markers of hormonal action and prostate cancer risk (INVITED), School of Population Health, Master of Public Health; 25 May 2006, Melbourne University, VI
Severi G. Predicting the individual risk of developing prostate cancer (INVITED), TCCV Seminar Series; 6 June 2006, The Cancer Council Victoria, Melbourne
